In summary, AI offers transformative potential in predicting resistance, uncovering hidden vulnerabilities, and personalizing therapeutic decisions, thus serving as a critical enabler in the era of data-driven oncology
(PubMed) Wu P, Ma J, Yang S, et al
One key pharmacologic distinction matters for hepatic impairment specifically
Ricaptos have more than 40 brands which are launched in the market
Mechanisms of action Preclinical studies document: Anxiolytic effect without sedation in classical tests (elevated plus maze, open field, light-dark box) GABAergic system modulation : allosteric potentiation of GABA-A observed ex vivo Enkephalin increase (endogenous opioid peptide) and serotonergic modulation Immunomodulatory effects inherited from tuftsin: macrophage activation, T-helper modulation Behavioural models Anxiolysis is measured via time spent in open arms of the elevated plus maze (EPM), visit ratio of central zones of open field , and exit latency in light-dark box